5% stakes
Broadwood Partners
Institution
- 5% stake reports
- 18
- 5% stake stocks
- 3
- Latest report
- 26/04/27
5% stake reports
| Stock | ||
|---|---|---|
| Insight Molecular Diagnostics IMDX04/27 | 39.7%12,835,134 sh | +2.3pp |
| Staar Surgical STAA03/13 | 32.6%16,149,742 sh | +1.5pp |
| Insight Molecular Diagnostics IMDX02/12 | 37.4%12,082,089 sh | −2.8pp |
| Staar Surgical STAA01/16 | 31.1%15,479,529 sh | +0.9pp |
| Staar Surgical STAA25/12/17 | 30.2%15,045,391 sh | +0.0pp |
| Staar Surgical STAA25/11/21 | 30.2%15,045,391 sh | +2.8pp |
| Lineage Cell Therapeutics LCTX25/11/14 | 23.1%57,848,357 sh | −1.4pp |
| Staar Surgical STAA25/10/24 | 27.4%13,545,391 sh | +0.0pp |
| Staar Surgical STAA25/10/22 | 27.4%13,545,391 sh | +0.0pp |
| Staar Surgical STAA25/09/26 | 27.4%13,545,391 sh | +0.0pp |
| Staar Surgical STAA25/09/17 | 27.4%13,545,391 sh | +0.1pp |
| Staar Surgical STAA25/09/02 | 27.3%13,545,391 sh | +0.0pp |
| Staar Surgical STAA25/08/08 | 27.3%13,545,391 sh | +0.2pp |
| Staar Surgical STAA25/04/07 | 27.1%13,358,164 sh | +1.7pp |
| Staar Surgical STAA25/04/02 | 25.4%12,512,944 sh | +1.1pp |
| Staar Surgical STAA25/03/03 | 24.3%11,979,098 sh | No earlier report |
| Insight Molecular Diagnostics IMDX25/02/10 | 40.2%11,560,350 sh | No earlier report |
| Lineage Cell Therapeutics LCTX25/01/28 | 24.5%57,848,357 sh | No earlier report |
